Zura Bio Ltd
ZURA Nasdaq· Biological Products, (No Diagnostic Substances)
Last close · Oct 26, 2026
$3.56
KIRA · Stoqly’s AI analyst, in plain words
- Zura Bio Ltd lost $68.7M in fiscal 2025.
- Free cash flow was −$64.9M in fiscal 2025, — of revenue.
Market cap
$451M
P/E
—
Revenue
—
Net income
−$68.7M
Free cash flow
−$64.9M
Operating margin
—
Zura Bio Ltd in 30 seconds · fiscal 2025
Does it make a profit?
−$68.7M
No. It lost money last year.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Zura Bio Ltd does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 19, 2026
- Legal name
- Zura Bio Ltd
- CIK
- 0001855644
Zura Bio Ltd · ZURA
Results and finances
The last 4 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Sales and profit | ||||
| Net income | −$25.7M | −$60.4M | −$52.4M | −$68.7M |
| Diluted EPS | — | −$2.09 | −$0.60 | −$1.06 |
| Cash | ||||
| Cash from operations | −$1.1M | −$15.1M | −$28.1M | −$64.8M |
| Capital expenditure | — | — | $0.1M | $0.1M |
| Free cash flow | — | — | −$28.2M | −$64.9M |
| Share count change | — | — | 127.0% | 25.4% |
| Debt and strength | ||||
| Cash and short-term investments | $0.0M | $99.8M | $176M | $109M |
| Shareholders' equity | −$32.1M | $59.3M | $147M | $102M |
| Current ratio | 0.1x | 5.0x | 9.2x | 9.1x |
| Returns and quality | ||||
| Return on equity | — | −442.6% | −50.8% | −55.3% |
| Return on tangible equity | — | −116.7% | −30.9% | −97.8% |
| Altman Z'' | −41.8 | 0.6 | 8.8 | 3.5 |
Insiders bought, 12 months
$12.5M
1 insider
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Zura Bio Ltd · ZURA
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $3.56 a share, the company is worth $451M.
Source: SEC EDGAR XBRL filings (CIK 0001855644). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.